← Back to Clinical Trials
Recruiting NCT07143357

NCT07143357 Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07143357
Status Recruiting
Phase
Sponsor Massachusetts General Hospital
Condition Emotional Distress
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2025-10-17
Primary Completion 2028-06

Trial Parameters

Condition Emotional Distress
Sponsor Massachusetts General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 84
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-10-17
Completion 2028-06
Interventions
Recovering Together after Cardiac Arrest 1Recovering Together after Cardiac Arrest 2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to pilot two resilience interventions for cardiac arrest survivors and their informal caregivers, Recovering Together after Cardiac Arrest 1 and Recovering Together after Cardiac Arrest 2 . The data the investigators gather in this study will be used to further refine the interventions.

Eligibility Criteria

Inclusion Criteria: 1. Out-of-hospital or in-hospital CA survivor (must have new diagnosis of "cardiac arrest" in electronic medical record from index hospitalization with documented loss of pulse) with an identified caregiver (identified by the survivor who is their primary source of emotional and functional support) 2. survivor must score \>5 on Short Form of the Mini Mental State Exam for sufficient cognitive function for meaningful participation 3. ability and willingness to participate in a hybrid in-person/live video intervention 4. English speaking adults (18 year or older) 5. at least one member of the dyad endorses clinically significant emotional distress during screening (\>7 on either of the Hospital Anxiety and Depression Scale subscales). Exclusion Criteria: 1. active psychosis, mania, substance dependence, or suicidal intent or plan that would require a higher level of care 2. any other psychiatric or neurological condition that would preclude meaningful participation 3.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology